Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Zosano Pharma Corporation

NASDAQ: ZSANHealthcare / Biotechnology / USA
2.29+0.0300+1.33%Vol 73 2451Y Perf -76.84%
Jan 18th, 2019 16:00
BID2.23 ASK2.29
Open2.23 Previous Close2.26
Pre-Market- After-Trading-
 - -%  - -%
Target Price
19.00 
Analyst Rating
Strong Buy 1.00
Potencial %
729.69 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)27 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.84 
Earnings Date
11th Mar 2019

Today's Price Range

2.052.30

 

52wk Range

1.8525.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-28.44%
3 Months
-44.42%
6 Months
-47.72%
1 Year
-76.84%
3 Years
-94.33%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ZSAN2.290.03001.33
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.20
Current Ratio
5.40
Long Term Debt to Total Capital
0.12
Total Debt to Equity
0.10
Interest Coverage
-43.10
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.10
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.20
Cash Flow Per Share
-4.11
Price to Tangible Book
1.10
Book Value per Share
2.38
Enterprise Value (in ths.)
1 774
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-435.88
ROE last 12 Months
-153.04
Return on Assets (5Y Avg)
-66.25
ROA last 12 Months
-101.03
Return on Capital (5Y Avg)
-
ROC last 12 Months
-153.04
Return on invested Capital Q
-25.30
Return on invested Capital Y
-234.29
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.75-
Q01 2018--4.16-
Q04 2017-4.80-3.8020.83
Q03 2017-3.00-4.00-33.33
Q02 2017-3.00-3.40-13.33
Q01 2017-6.00-6.80-13.33
Q04 2016-9.00-9.20-2.22
Q03 2016-13.00-10.4020.00
Earnings Per EndEstimateRevision %Trend
3/2018 QR-5.400.00-
6/2018 QR-4.200.00-
12/2018 FY-18.000.00-
12/2018 FY-18.000.00-
Next Report Date11th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume73 245
Shares Outstanding (in ths.)11 973
Trades Count292
Dollar Volume154 404
Avg. Volume114 541
Avg. Weekly Volume132 288
Avg. Monthly Volume175 452
Avg. Quarterly Volume112 004

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News